Spanish Red Biotech Pipeline

MSD

Nemtabrutinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies.
Phase: 2Phase II in Spain, 1Phase I